nodes	percent_of_prediction	percent_of_DWPC	metapath
Rasagiline—CYP1A2—Proguanil—malaria	0.178	0.341	CbGbCtD
Rasagiline—CYP1A2—Pentoxifylline—malaria	0.128	0.245	CbGbCtD
Rasagiline—CYP1A2—Quinine—malaria	0.115	0.22	CbGbCtD
Rasagiline—CYP1A2—Quinidine—malaria	0.101	0.193	CbGbCtD
Rasagiline—BCL2—hematopoietic system—malaria	0.0101	0.117	CbGeAlD
Rasagiline—BCL2—kidney—malaria	0.00831	0.0962	CbGeAlD
Rasagiline—MAOB—blood plasma—malaria	0.00764	0.0884	CbGeAlD
Rasagiline—BCL2—digestive system—malaria	0.00705	0.0816	CbGeAlD
Rasagiline—BCL2—blood—malaria	0.00672	0.0778	CbGeAlD
Rasagiline—BCL2—bone marrow—malaria	0.0065	0.0753	CbGeAlD
Rasagiline—CYP1A2—blood plasma—malaria	0.00544	0.0629	CbGeAlD
Rasagiline—MAOB—saliva-secreting gland—malaria	0.00443	0.0512	CbGeAlD
Rasagiline—MAOB—hematopoietic system—malaria	0.00422	0.0489	CbGeAlD
Rasagiline—BCL2—brain—malaria	0.00417	0.0483	CbGeAlD
Rasagiline—BCL2—IL-2 Signaling Pathway—CISH—malaria	0.00392	0.0917	CbGpPWpGaD
Rasagiline—MAOB—kidney—malaria	0.00346	0.0401	CbGeAlD
Rasagiline—BCL2—IL2-mediated signaling events—CISH—malaria	0.00321	0.075	CbGpPWpGaD
Rasagiline—CYP1A2—hematopoietic system—malaria	0.00301	0.0348	CbGeAlD
Rasagiline—MAOB—digestive system—malaria	0.00294	0.034	CbGeAlD
Rasagiline—MAOB—blood—malaria	0.0028	0.0324	CbGeAlD
Rasagiline—MAOB—liver—malaria	0.00219	0.0253	CbGeAlD
Rasagiline—CYP1A2—digestive system—malaria	0.00209	0.0242	CbGeAlD
Rasagiline—BCL2—Overview of nanoparticle effects—CRP—malaria	0.00205	0.0478	CbGpPWpGaD
Rasagiline—CYP1A2—blood—malaria	0.00199	0.0231	CbGeAlD
Rasagiline—MAOB—brain—malaria	0.00174	0.0201	CbGeAlD
Rasagiline—BCL2—IL2 signaling events mediated by STAT5—IL4—malaria	0.00164	0.0384	CbGpPWpGaD
Rasagiline—CYP1A2—liver—malaria	0.00156	0.018	CbGeAlD
Rasagiline—BCL2—HIV-1 Nef: Negative effector of Fas and TNF-alpha—FAS—malaria	0.0014	0.0328	CbGpPWpGaD
Rasagiline—BCL2—FAS pathway and Stress induction of HSP regulation—FAS—malaria	0.00116	0.027	CbGpPWpGaD
Rasagiline—BCL2—Interleukin-11 Signaling Pathway—ICAM1—malaria	0.00096	0.0224	CbGpPWpGaD
Rasagiline—BCL2—Overview of nanoparticle effects—TNF—malaria	0.000926	0.0216	CbGpPWpGaD
Rasagiline—BCL2—Caspase Cascade in Apoptosis—FAS—malaria	0.000906	0.0212	CbGpPWpGaD
Rasagiline—BCL2—IL2 signaling events mediated by STAT5—IL2—malaria	0.000882	0.0206	CbGpPWpGaD
Rasagiline—BCL2—ATF-2 transcription factor network—NOS2—malaria	0.000753	0.0176	CbGpPWpGaD
Rasagiline—BCL2—Overview of nanoparticle effects—IL6—malaria	0.000747	0.0175	CbGpPWpGaD
Rasagiline—BCL2—IL2 signaling events mediated by PI3K—IL2—malaria	0.000746	0.0174	CbGpPWpGaD
Rasagiline—BCL2—RXR and RAR heterodimerization with other nuclear receptor—TNF—malaria	0.00072	0.0168	CbGpPWpGaD
Rasagiline—Urethral disorder—Quinidine—malaria	0.000714	0.00205	CcSEcCtD
Rasagiline—Jaundice—Quinidine barbiturate—malaria	0.000713	0.00205	CcSEcCtD
Rasagiline—Jaundice—Pentoxifylline—malaria	0.000712	0.00204	CcSEcCtD
Rasagiline—Conjunctivitis—Pentoxifylline—malaria	0.00071	0.00204	CcSEcCtD
Rasagiline—Sweating—Quinidine barbiturate—malaria	0.000702	0.00201	CcSEcCtD
Rasagiline—BCL2—IL-5 Signaling Pathway—IL2—malaria	0.000701	0.0164	CbGpPWpGaD
Rasagiline—Sweating—Pentoxifylline—malaria	0.0007	0.00201	CcSEcCtD
Rasagiline—MAOB—Biological oxidations—HPGDS—malaria	0.000696	0.0163	CbGpPWpGaD
Rasagiline—BCL2—Corticotropin-releasing hormone—IL18—malaria	0.000691	0.0162	CbGpPWpGaD
Rasagiline—Epistaxis—Pentoxifylline—malaria	0.000689	0.00198	CcSEcCtD
Rasagiline—Eye disorder—Quinidine—malaria	0.00068	0.00195	CcSEcCtD
Rasagiline—Eye disorder—Quinine—malaria	0.00068	0.00195	CcSEcCtD
Rasagiline—Vomiting—Proguanil—malaria	0.000678	0.00195	CcSEcCtD
Rasagiline—Cardiac disorder—Quinidine—malaria	0.000676	0.00194	CcSEcCtD
Rasagiline—Cardiac disorder—Quinine—malaria	0.000676	0.00194	CcSEcCtD
Rasagiline—Anorexia—Sulfadiazine—malaria	0.000675	0.00194	CcSEcCtD
Rasagiline—BCL2—IL-2 Signaling Pathway—IL2—malaria	0.000674	0.0157	CbGpPWpGaD
Rasagiline—Rash—Proguanil—malaria	0.000673	0.00193	CcSEcCtD
Rasagiline—Dermatitis—Proguanil—malaria	0.000672	0.00193	CcSEcCtD
Rasagiline—Headache—Proguanil—malaria	0.000668	0.00192	CcSEcCtD
Rasagiline—BCL2—Apoptosis—FAS—malaria	0.000664	0.0155	CbGpPWpGaD
Rasagiline—Haemoglobin—Quinidine barbiturate—malaria	0.00066	0.00189	CcSEcCtD
Rasagiline—Haemoglobin—Pentoxifylline—malaria	0.000659	0.00189	CcSEcCtD
Rasagiline—Immune system disorder—Quinidine—malaria	0.000658	0.00189	CcSEcCtD
Rasagiline—Immune system disorder—Quinine—malaria	0.000658	0.00189	CcSEcCtD
Rasagiline—Haemorrhage—Quinidine barbiturate—malaria	0.000657	0.00188	CcSEcCtD
Rasagiline—Mediastinal disorder—Quinidine—malaria	0.000656	0.00188	CcSEcCtD
Rasagiline—Mediastinal disorder—Quinine—malaria	0.000656	0.00188	CcSEcCtD
Rasagiline—Haemorrhage—Pentoxifylline—malaria	0.000656	0.00188	CcSEcCtD
Rasagiline—Hallucination—Quinidine barbiturate—malaria	0.000654	0.00188	CcSEcCtD
Rasagiline—Chills—Quinidine—malaria	0.000653	0.00187	CcSEcCtD
Rasagiline—Chills—Quinine—malaria	0.000653	0.00187	CcSEcCtD
Rasagiline—Urinary tract disorder—Quinidine barbiturate—malaria	0.000649	0.00186	CcSEcCtD
Rasagiline—Musculoskeletal discomfort—Sulfadiazine—malaria	0.000645	0.00185	CcSEcCtD
Rasagiline—Urethral disorder—Quinidine barbiturate—malaria	0.000644	0.00185	CcSEcCtD
Rasagiline—Insomnia—Sulfadiazine—malaria	0.00064	0.00184	CcSEcCtD
Rasagiline—Mental disorder—Quinine—malaria	0.000638	0.00183	CcSEcCtD
Rasagiline—Mental disorder—Quinidine—malaria	0.000638	0.00183	CcSEcCtD
Rasagiline—Flatulence—Clindamycin—malaria	0.000637	0.00183	CcSEcCtD
Rasagiline—Malnutrition—Quinidine—malaria	0.000634	0.00182	CcSEcCtD
Rasagiline—Malnutrition—Quinine—malaria	0.000634	0.00182	CcSEcCtD
Rasagiline—Nausea—Proguanil—malaria	0.000634	0.00182	CcSEcCtD
Rasagiline—Dysgeusia—Clindamycin—malaria	0.000633	0.00181	CcSEcCtD
Rasagiline—Back pain—Clindamycin—malaria	0.000625	0.00179	CcSEcCtD
Rasagiline—BCL2—Apoptosis Modulation and Signaling—FAS—malaria	0.000623	0.0146	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—HPGDS—malaria	0.000621	0.0145	CbGpPWpGaD
Rasagiline—Muscle spasms—Clindamycin—malaria	0.000621	0.00178	CcSEcCtD
Rasagiline—BCL2—IL2-mediated signaling events—IFNG—malaria	0.00062	0.0145	CbGpPWpGaD
Rasagiline—Decreased appetite—Sulfadiazine—malaria	0.000616	0.00177	CcSEcCtD
Rasagiline—Eye disorder—Quinidine barbiturate—malaria	0.000614	0.00176	CcSEcCtD
Rasagiline—Gastrointestinal disorder—Sulfadiazine—malaria	0.000611	0.00175	CcSEcCtD
Rasagiline—Cardiac disorder—Quinidine barbiturate—malaria	0.00061	0.00175	CcSEcCtD
Rasagiline—Vertigo—Dapsone—malaria	0.0006	0.00172	CcSEcCtD
Rasagiline—Anaemia—Clindamycin—malaria	0.000597	0.00171	CcSEcCtD
Rasagiline—BCL2—HIV-1 Nef: Negative effector of Fas and TNF-alpha—TNF—malaria	0.000595	0.0139	CbGpPWpGaD
Rasagiline—Tremor—Quinine—malaria	0.000594	0.0017	CcSEcCtD
Rasagiline—Tremor—Quinidine—malaria	0.000594	0.0017	CcSEcCtD
Rasagiline—Immune system disorder—Quinidine barbiturate—malaria	0.000594	0.0017	CcSEcCtD
Rasagiline—Immune system disorder—Pentoxifylline—malaria	0.000592	0.0017	CcSEcCtD
Rasagiline—Mediastinal disorder—Quinidine barbiturate—malaria	0.000592	0.0017	CcSEcCtD
Rasagiline—Chills—Quinidine barbiturate—malaria	0.00059	0.00169	CcSEcCtD
Rasagiline—Cough—Dapsone—malaria	0.000583	0.00167	CcSEcCtD
Rasagiline—Agitation—Quinidine—malaria	0.000582	0.00167	CcSEcCtD
Rasagiline—Agitation—Quinine—malaria	0.000582	0.00167	CcSEcCtD
Rasagiline—Vertigo—Clindamycin—malaria	0.00058	0.00166	CcSEcCtD
Rasagiline—Gastrointestinal pain—Sulfadiazine—malaria	0.000579	0.00166	CcSEcCtD
Rasagiline—Leukopenia—Clindamycin—malaria	0.000578	0.00166	CcSEcCtD
Rasagiline—BCL2—ATF-2 transcription factor network—IFNG—malaria	0.000578	0.0135	CbGpPWpGaD
Rasagiline—Mental disorder—Quinidine barbiturate—malaria	0.000576	0.00165	CcSEcCtD
Rasagiline—Malnutrition—Quinidine barbiturate—malaria	0.000572	0.00164	CcSEcCtD
Rasagiline—Vertigo—Quinine—malaria	0.000569	0.00163	CcSEcCtD
Rasagiline—Vertigo—Quinidine—malaria	0.000569	0.00163	CcSEcCtD
Rasagiline—Syncope—Quinidine—malaria	0.000568	0.00163	CcSEcCtD
Rasagiline—Syncope—Quinine—malaria	0.000568	0.00163	CcSEcCtD
Rasagiline—Leukopenia—Quinine—malaria	0.000567	0.00163	CcSEcCtD
Rasagiline—Leukopenia—Quinidine—malaria	0.000567	0.00163	CcSEcCtD
Rasagiline—Flatulence—Pentoxifylline—malaria	0.000563	0.00161	CcSEcCtD
Rasagiline—Urticaria—Sulfadiazine—malaria	0.000563	0.00161	CcSEcCtD
Rasagiline—Abdominal pain—Sulfadiazine—malaria	0.00056	0.00161	CcSEcCtD
Rasagiline—Body temperature increased—Sulfadiazine—malaria	0.00056	0.00161	CcSEcCtD
Rasagiline—Dysgeusia—Pentoxifylline—malaria	0.000559	0.0016	CcSEcCtD
Rasagiline—Hypertension—Clindamycin—malaria	0.000558	0.0016	CcSEcCtD
Rasagiline—Loss of consciousness—Quinine—malaria	0.000557	0.0016	CcSEcCtD
Rasagiline—Loss of consciousness—Quinidine—malaria	0.000557	0.0016	CcSEcCtD
Rasagiline—BCL2—Corticotropin-releasing hormone—TLR4—malaria	0.000555	0.013	CbGpPWpGaD
Rasagiline—Back pain—Pentoxifylline—malaria	0.000552	0.00158	CcSEcCtD
Rasagiline—BCL2—IL2-mediated signaling events—IL2—malaria	0.000551	0.0129	CbGpPWpGaD
Rasagiline—Convulsion—Quinine—malaria	0.000549	0.00158	CcSEcCtD
Rasagiline—Convulsion—Quinidine—malaria	0.000549	0.00158	CcSEcCtD
Rasagiline—Muscle spasms—Pentoxifylline—malaria	0.000549	0.00157	CcSEcCtD
Rasagiline—Discomfort—Clindamycin—malaria	0.000543	0.00156	CcSEcCtD
Rasagiline—Chest pain—Quinine—malaria	0.00054	0.00155	CcSEcCtD
Rasagiline—Chest pain—Quinidine—malaria	0.00054	0.00155	CcSEcCtD
Rasagiline—Tremor—Quinidine barbiturate—malaria	0.000536	0.00154	CcSEcCtD
Rasagiline—Unspecified disorder of skin and subcutaneous tissue—Quinine—malaria	0.000536	0.00154	CcSEcCtD
Rasagiline—Unspecified disorder of skin and subcutaneous tissue—Quinidine—malaria	0.000536	0.00154	CcSEcCtD
Rasagiline—Tremor—Pentoxifylline—malaria	0.000535	0.00153	CcSEcCtD
Rasagiline—BCL2—Amyotrophic lateral sclerosis (ALS)—TNF—malaria	0.000532	0.0124	CbGpPWpGaD
Rasagiline—Ill-defined disorder—Pentoxifylline—malaria	0.00053	0.00152	CcSEcCtD
Rasagiline—Anaemia—Pentoxifylline—malaria	0.000528	0.00151	CcSEcCtD
Rasagiline—Agitation—Quinidine barbiturate—malaria	0.000526	0.00151	CcSEcCtD
Rasagiline—Agitation—Pentoxifylline—malaria	0.000525	0.0015	CcSEcCtD
Rasagiline—Hypersensitivity—Sulfadiazine—malaria	0.000522	0.0015	CcSEcCtD
Rasagiline—Confusional state—Quinine—malaria	0.000522	0.0015	CcSEcCtD
Rasagiline—Confusional state—Quinidine—malaria	0.000522	0.0015	CcSEcCtD
Rasagiline—Malaise—Pentoxifylline—malaria	0.000515	0.00148	CcSEcCtD
Rasagiline—Vertigo—Quinidine barbiturate—malaria	0.000514	0.00147	CcSEcCtD
Rasagiline—Syncope—Quinidine barbiturate—malaria	0.000513	0.00147	CcSEcCtD
Rasagiline—Leukopenia—Quinidine barbiturate—malaria	0.000512	0.00147	CcSEcCtD
Rasagiline—Leukopenia—Pentoxifylline—malaria	0.000511	0.00147	CcSEcCtD
Rasagiline—Shock—Quinine—malaria	0.000509	0.00146	CcSEcCtD
Rasagiline—Shock—Quinidine—malaria	0.000509	0.00146	CcSEcCtD
Rasagiline—Nervous system disorder—Quinine—malaria	0.000507	0.00145	CcSEcCtD
Rasagiline—Nervous system disorder—Quinidine—malaria	0.000507	0.00145	CcSEcCtD
Rasagiline—Loss of consciousness—Quinidine barbiturate—malaria	0.000503	0.00144	CcSEcCtD
Rasagiline—Skin disorder—Quinine—malaria	0.000502	0.00144	CcSEcCtD
Rasagiline—Skin disorder—Quinidine—malaria	0.000502	0.00144	CcSEcCtD
Rasagiline—Pruritus—Sulfadiazine—malaria	0.000501	0.00144	CcSEcCtD
Rasagiline—Hyperhidrosis—Quinine—malaria	0.0005	0.00143	CcSEcCtD
Rasagiline—Hyperhidrosis—Quinidine—malaria	0.0005	0.00143	CcSEcCtD
Rasagiline—Convulsion—Quinidine barbiturate—malaria	0.000496	0.00142	CcSEcCtD
Rasagiline—Convulsion—Pentoxifylline—malaria	0.000495	0.00142	CcSEcCtD
Rasagiline—Anorexia—Quinidine—malaria	0.000493	0.00141	CcSEcCtD
Rasagiline—Anorexia—Quinine—malaria	0.000493	0.00141	CcSEcCtD
Rasagiline—Insomnia—Dapsone—malaria	0.000493	0.00141	CcSEcCtD
Rasagiline—Hypertension—Pentoxifylline—malaria	0.000493	0.00141	CcSEcCtD
Rasagiline—Hypotension—Clindamycin—malaria	0.000493	0.00141	CcSEcCtD
Rasagiline—BCL2—FAS pathway and Stress induction of HSP regulation—TNF—malaria	0.000491	0.0115	CbGpPWpGaD
Rasagiline—Arthralgia—Quinidine barbiturate—malaria	0.000487	0.0014	CcSEcCtD
Rasagiline—Chest pain—Quinidine barbiturate—malaria	0.000487	0.0014	CcSEcCtD
Rasagiline—Chest pain—Pentoxifylline—malaria	0.000486	0.00139	CcSEcCtD
Rasagiline—Anxiety—Quinidine barbiturate—malaria	0.000485	0.00139	CcSEcCtD
Rasagiline—Diarrhoea—Sulfadiazine—malaria	0.000484	0.00139	CcSEcCtD
Rasagiline—Anxiety—Pentoxifylline—malaria	0.000484	0.00139	CcSEcCtD
Rasagiline—Unspecified disorder of skin and subcutaneous tissue—Quinidine barbiturate—malaria	0.000484	0.00139	CcSEcCtD
Rasagiline—Hypotension—Quinine—malaria	0.000483	0.00139	CcSEcCtD
Rasagiline—Hypotension—Quinidine—malaria	0.000483	0.00139	CcSEcCtD
Rasagiline—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—malaria	0.000483	0.00138	CcSEcCtD
Rasagiline—Discomfort—Pentoxifylline—malaria	0.00048	0.00138	CcSEcCtD
Rasagiline—Dry mouth—Pentoxifylline—malaria	0.000475	0.00136	CcSEcCtD
Rasagiline—Musculoskeletal discomfort—Quinidine—malaria	0.000471	0.00135	CcSEcCtD
Rasagiline—Musculoskeletal discomfort—Quinine—malaria	0.000471	0.00135	CcSEcCtD
Rasagiline—Confusional state—Quinidine barbiturate—malaria	0.000471	0.00135	CcSEcCtD
Rasagiline—Dyspnoea—Clindamycin—malaria	0.00047	0.00135	CcSEcCtD
Rasagiline—Confusional state—Pentoxifylline—malaria	0.00047	0.00135	CcSEcCtD
Rasagiline—Dyspepsia—Clindamycin—malaria	0.000464	0.00133	CcSEcCtD
Rasagiline—Infection—Pentoxifylline—malaria	0.000463	0.00133	CcSEcCtD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—HPGDS—malaria	0.000462	0.0108	CbGpPWpGaD
Rasagiline—Dyspnoea—Quinidine—malaria	0.000461	0.00132	CcSEcCtD
Rasagiline—Dyspnoea—Quinine—malaria	0.000461	0.00132	CcSEcCtD
Rasagiline—Shock—Quinidine barbiturate—malaria	0.000459	0.00132	CcSEcCtD
Rasagiline—Shock—Pentoxifylline—malaria	0.000458	0.00131	CcSEcCtD
Rasagiline—Nervous system disorder—Quinidine barbiturate—malaria	0.000458	0.00131	CcSEcCtD
Rasagiline—Gastrointestinal disorder—Clindamycin—malaria	0.000455	0.00131	CcSEcCtD
Rasagiline—Skin disorder—Quinidine barbiturate—malaria	0.000453	0.0013	CcSEcCtD
Rasagiline—Skin disorder—Pentoxifylline—malaria	0.000453	0.0013	CcSEcCtD
Rasagiline—Hyperhidrosis—Quinidine barbiturate—malaria	0.000451	0.00129	CcSEcCtD
Rasagiline—Constipation—Clindamycin—malaria	0.000451	0.00129	CcSEcCtD
Rasagiline—Hyperhidrosis—Pentoxifylline—malaria	0.00045	0.00129	CcSEcCtD
Rasagiline—Vomiting—Sulfadiazine—malaria	0.00045	0.00129	CcSEcCtD
Rasagiline—Decreased appetite—Quinidine—malaria	0.00045	0.00129	CcSEcCtD
Rasagiline—Decreased appetite—Quinine—malaria	0.00045	0.00129	CcSEcCtD
Rasagiline—Gastrointestinal disorder—Quinidine—malaria	0.000447	0.00128	CcSEcCtD
Rasagiline—Gastrointestinal disorder—Quinine—malaria	0.000447	0.00128	CcSEcCtD
Rasagiline—Rash—Sulfadiazine—malaria	0.000446	0.00128	CcSEcCtD
Rasagiline—Dermatitis—Sulfadiazine—malaria	0.000446	0.00128	CcSEcCtD
Rasagiline—Gastrointestinal pain—Dapsone—malaria	0.000446	0.00128	CcSEcCtD
Rasagiline—Anorexia—Quinidine barbiturate—malaria	0.000445	0.00128	CcSEcCtD
Rasagiline—Anorexia—Pentoxifylline—malaria	0.000444	0.00127	CcSEcCtD
Rasagiline—Headache—Sulfadiazine—malaria	0.000444	0.00127	CcSEcCtD
Rasagiline—BCL2—Direct p53 effectors—FAS—malaria	0.000441	0.0103	CbGpPWpGaD
Rasagiline—BCL2—Ceramide signaling pathway—TNF—malaria	0.000441	0.0103	CbGpPWpGaD
Rasagiline—Hypotension—Quinidine barbiturate—malaria	0.000436	0.00125	CcSEcCtD
Rasagiline—Hypotension—Pentoxifylline—malaria	0.000435	0.00125	CcSEcCtD
Rasagiline—CYP1A2—Arachidonic acid metabolism—HPGDS—malaria	0.000433	0.0101	CbGpPWpGaD
Rasagiline—Gastrointestinal pain—Clindamycin—malaria	0.000431	0.00124	CcSEcCtD
Rasagiline—Abdominal pain—Dapsone—malaria	0.000431	0.00124	CcSEcCtD
Rasagiline—Body temperature increased—Dapsone—malaria	0.000431	0.00124	CcSEcCtD
Rasagiline—Feeling abnormal—Quinidine—malaria	0.000426	0.00122	CcSEcCtD
Rasagiline—Feeling abnormal—Quinine—malaria	0.000426	0.00122	CcSEcCtD
Rasagiline—Musculoskeletal discomfort—Quinidine barbiturate—malaria	0.000425	0.00122	CcSEcCtD
Rasagiline—Musculoskeletal discomfort—Pentoxifylline—malaria	0.000425	0.00122	CcSEcCtD
Rasagiline—Gastrointestinal pain—Quinine—malaria	0.000423	0.00121	CcSEcCtD
Rasagiline—Gastrointestinal pain—Quinidine—malaria	0.000423	0.00121	CcSEcCtD
Rasagiline—Insomnia—Pentoxifylline—malaria	0.000421	0.00121	CcSEcCtD
Rasagiline—BCL2—C-MYB transcription factor network—CD4—malaria	0.000421	0.00983	CbGpPWpGaD
Rasagiline—Nausea—Sulfadiazine—malaria	0.000421	0.00121	CcSEcCtD
Rasagiline—Urticaria—Clindamycin—malaria	0.000419	0.0012	CcSEcCtD
Rasagiline—Body temperature increased—Clindamycin—malaria	0.000417	0.0012	CcSEcCtD
Rasagiline—Abdominal pain—Clindamycin—malaria	0.000417	0.0012	CcSEcCtD
Rasagiline—Dyspnoea—Quinidine barbiturate—malaria	0.000416	0.00119	CcSEcCtD
Rasagiline—Dyspnoea—Pentoxifylline—malaria	0.000415	0.00119	CcSEcCtD
Rasagiline—Somnolence—Quinidine barbiturate—malaria	0.000415	0.00119	CcSEcCtD
Rasagiline—Somnolence—Pentoxifylline—malaria	0.000414	0.00119	CcSEcCtD
Rasagiline—Urticaria—Quinidine—malaria	0.000411	0.00118	CcSEcCtD
Rasagiline—Urticaria—Quinine—malaria	0.000411	0.00118	CcSEcCtD
Rasagiline—Dyspepsia—Pentoxifylline—malaria	0.00041	0.00118	CcSEcCtD
Rasagiline—Abdominal pain—Quinidine—malaria	0.000409	0.00117	CcSEcCtD
Rasagiline—Abdominal pain—Quinine—malaria	0.000409	0.00117	CcSEcCtD
Rasagiline—Body temperature increased—Quinidine—malaria	0.000409	0.00117	CcSEcCtD
Rasagiline—Body temperature increased—Quinine—malaria	0.000409	0.00117	CcSEcCtD
Rasagiline—BCL2—Apoptosis—FAS—malaria	0.000407	0.00951	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—TIRAP—malaria	0.000406	0.00949	CbGpPWpGaD
Rasagiline—Decreased appetite—Quinidine barbiturate—malaria	0.000406	0.00116	CcSEcCtD
Rasagiline—Decreased appetite—Pentoxifylline—malaria	0.000405	0.00116	CcSEcCtD
Rasagiline—Gastrointestinal disorder—Quinidine barbiturate—malaria	0.000403	0.00116	CcSEcCtD
Rasagiline—Constipation—Quinidine barbiturate—malaria	0.000399	0.00115	CcSEcCtD
Rasagiline—Constipation—Pentoxifylline—malaria	0.000398	0.00114	CcSEcCtD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—malaria	0.000391	0.00913	CbGpPWpGaD
Rasagiline—Hypersensitivity—Clindamycin—malaria	0.000388	0.00111	CcSEcCtD
Rasagiline—Feeling abnormal—Quinidine barbiturate—malaria	0.000385	0.0011	CcSEcCtD
Rasagiline—BCL2—Caspase Cascade in Apoptosis—TNF—malaria	0.000384	0.00898	CbGpPWpGaD
Rasagiline—Feeling abnormal—Pentoxifylline—malaria	0.000384	0.0011	CcSEcCtD
Rasagiline—Gastrointestinal pain—Quinidine barbiturate—malaria	0.000382	0.00109	CcSEcCtD
Rasagiline—Hypersensitivity—Quinine—malaria	0.000381	0.00109	CcSEcCtD
Rasagiline—Hypersensitivity—Quinidine—malaria	0.000381	0.00109	CcSEcCtD
Rasagiline—Gastrointestinal pain—Pentoxifylline—malaria	0.000381	0.00109	CcSEcCtD
Rasagiline—Asthenia—Clindamycin—malaria	0.000378	0.00109	CcSEcCtD
Rasagiline—BCL2—Innate Immune System—CR1—malaria	0.000378	0.00882	CbGpPWpGaD
Rasagiline—Pruritus—Clindamycin—malaria	0.000373	0.00107	CcSEcCtD
Rasagiline—Asthenia—Quinidine—malaria	0.000371	0.00106	CcSEcCtD
Rasagiline—Asthenia—Quinine—malaria	0.000371	0.00106	CcSEcCtD
Rasagiline—Urticaria—Quinidine barbiturate—malaria	0.000371	0.00106	CcSEcCtD
Rasagiline—Urticaria—Pentoxifylline—malaria	0.00037	0.00106	CcSEcCtD
Rasagiline—Abdominal pain—Quinidine barbiturate—malaria	0.000369	0.00106	CcSEcCtD
Rasagiline—Body temperature increased—Quinidine barbiturate—malaria	0.000369	0.00106	CcSEcCtD
Rasagiline—Body temperature increased—Pentoxifylline—malaria	0.000368	0.00106	CcSEcCtD
Rasagiline—Abdominal pain—Pentoxifylline—malaria	0.000368	0.00106	CcSEcCtD
Rasagiline—Pruritus—Quinidine—malaria	0.000366	0.00105	CcSEcCtD
Rasagiline—Pruritus—Quinine—malaria	0.000366	0.00105	CcSEcCtD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—IFNG—malaria	0.000364	0.00851	CbGpPWpGaD
Rasagiline—Diarrhoea—Clindamycin—malaria	0.000361	0.00103	CcSEcCtD
Rasagiline—BCL2—Corticotropin-releasing hormone—IL2—malaria	0.00036	0.00841	CbGpPWpGaD
Rasagiline—Diarrhoea—Quinine—malaria	0.000354	0.00102	CcSEcCtD
Rasagiline—Diarrhoea—Quinidine—malaria	0.000354	0.00102	CcSEcCtD
Rasagiline—Dizziness—Clindamycin—malaria	0.000349	0.001	CcSEcCtD
Rasagiline—Vomiting—Dapsone—malaria	0.000347	0.000994	CcSEcCtD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—FAS—malaria	0.000344	0.00804	CbGpPWpGaD
Rasagiline—Hypersensitivity—Quinidine barbiturate—malaria	0.000344	0.000986	CcSEcCtD
Rasagiline—Hypersensitivity—Pentoxifylline—malaria	0.000343	0.000985	CcSEcCtD
Rasagiline—Dizziness—Quinine—malaria	0.000342	0.000981	CcSEcCtD
Rasagiline—Dizziness—Quinidine—malaria	0.000342	0.000981	CcSEcCtD
Rasagiline—Headache—Dapsone—malaria	0.000341	0.000979	CcSEcCtD
Rasagiline—Vomiting—Clindamycin—malaria	0.000335	0.000962	CcSEcCtD
Rasagiline—Asthenia—Quinidine barbiturate—malaria	0.000335	0.000961	CcSEcCtD
Rasagiline—Asthenia—Pentoxifylline—malaria	0.000334	0.000959	CcSEcCtD
Rasagiline—Rash—Clindamycin—malaria	0.000332	0.000954	CcSEcCtD
Rasagiline—Dermatitis—Clindamycin—malaria	0.000332	0.000953	CcSEcCtD
Rasagiline—Headache—Clindamycin—malaria	0.00033	0.000947	CcSEcCtD
Rasagiline—Pruritus—Quinidine barbiturate—malaria	0.00033	0.000947	CcSEcCtD
Rasagiline—Pruritus—Pentoxifylline—malaria	0.00033	0.000946	CcSEcCtD
Rasagiline—Vomiting—Quinidine—malaria	0.000329	0.000943	CcSEcCtD
Rasagiline—Vomiting—Quinine—malaria	0.000329	0.000943	CcSEcCtD
Rasagiline—Rash—Quinine—malaria	0.000326	0.000935	CcSEcCtD
Rasagiline—Rash—Quinidine—malaria	0.000326	0.000935	CcSEcCtD
Rasagiline—Dermatitis—Quinidine—malaria	0.000326	0.000935	CcSEcCtD
Rasagiline—Dermatitis—Quinine—malaria	0.000326	0.000935	CcSEcCtD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—IL1B—malaria	0.000325	0.0076	CbGpPWpGaD
Rasagiline—Headache—Quinidine—malaria	0.000324	0.000929	CcSEcCtD
Rasagiline—Headache—Quinine—malaria	0.000324	0.000929	CcSEcCtD
Rasagiline—Nausea—Dapsone—malaria	0.000324	0.000929	CcSEcCtD
Rasagiline—BCL2—Innate Immune System—TLR9—malaria	0.000321	0.0075	CbGpPWpGaD
Rasagiline—Diarrhoea—Quinidine barbiturate—malaria	0.000319	0.000916	CcSEcCtD
Rasagiline—Diarrhoea—Pentoxifylline—malaria	0.000319	0.000914	CcSEcCtD
Rasagiline—Nausea—Clindamycin—malaria	0.000313	0.000898	CcSEcCtD
Rasagiline—BCL2—Focal Adhesion—KDR—malaria	0.000311	0.00726	CbGpPWpGaD
Rasagiline—Dizziness—Quinidine barbiturate—malaria	0.000309	0.000885	CcSEcCtD
Rasagiline—Dizziness—Pentoxifylline—malaria	0.000308	0.000884	CcSEcCtD
Rasagiline—Nausea—Quinine—malaria	0.000307	0.000881	CcSEcCtD
Rasagiline—Nausea—Quinidine—malaria	0.000307	0.000881	CcSEcCtD
Rasagiline—BCL2—ATF-2 transcription factor network—IL6—malaria	0.000302	0.00705	CbGpPWpGaD
Rasagiline—Vomiting—Quinidine barbiturate—malaria	0.000297	0.000851	CcSEcCtD
Rasagiline—Vomiting—Pentoxifylline—malaria	0.000296	0.00085	CcSEcCtD
Rasagiline—Rash—Quinidine barbiturate—malaria	0.000294	0.000844	CcSEcCtD
Rasagiline—Dermatitis—Quinidine barbiturate—malaria	0.000294	0.000843	CcSEcCtD
Rasagiline—Rash—Pentoxifylline—malaria	0.000294	0.000843	CcSEcCtD
Rasagiline—Dermatitis—Pentoxifylline—malaria	0.000294	0.000842	CcSEcCtD
Rasagiline—Headache—Quinidine barbiturate—malaria	0.000292	0.000839	CcSEcCtD
Rasagiline—Headache—Pentoxifylline—malaria	0.000292	0.000837	CcSEcCtD
Rasagiline—BCL2—Apoptosis—TNF—malaria	0.000282	0.00659	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CISH—malaria	0.000281	0.00657	CbGpPWpGaD
Rasagiline—Nausea—Quinidine barbiturate—malaria	0.000277	0.000795	CcSEcCtD
Rasagiline—Nausea—Pentoxifylline—malaria	0.000277	0.000794	CcSEcCtD
Rasagiline—CYP1A2—Phase II conjugation—HPGDS—malaria	0.000275	0.00643	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—DHODH—malaria	0.000272	0.00635	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—CD36—malaria	0.000266	0.00623	CbGpPWpGaD
Rasagiline—BCL2—Immune System—FCGR2B—malaria	0.000265	0.0062	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—FCGR2A—malaria	0.000257	0.006	CbGpPWpGaD
Rasagiline—BCL2—Immune System—TIRAP—malaria	0.000237	0.00553	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—SLC4A1—malaria	0.000231	0.0054	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CR1—malaria	0.00022	0.00514	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—DECR1—malaria	0.000217	0.00507	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—HBB—malaria	0.000196	0.00459	CbGpPWpGaD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—IL6—malaria	0.00019	0.00445	CbGpPWpGaD
Rasagiline—BCL2—Immune System—TLR9—malaria	0.000187	0.00437	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PKLR—malaria	0.000175	0.00409	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—TNF—malaria	0.000173	0.00404	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—malaria	0.000168	0.00393	CbGpPWpGaD
Rasagiline—CYP1A2—Biological oxidations—HPGDS—malaria	0.000161	0.00376	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—G6PD—malaria	0.000156	0.00365	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—HLA-B—malaria	0.000151	0.00352	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—malaria	0.00015	0.0035	CbGpPWpGaD
Rasagiline—BCL2—Immune System—FCGR2A—malaria	0.000149	0.00349	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—malaria	0.000149	0.00349	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—CD36—malaria	0.000148	0.00346	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—TNF—malaria	0.000146	0.00341	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—CRP—malaria	0.000133	0.00312	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—TLR4—malaria	0.000128	0.00299	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—HPGDS—malaria	0.000119	0.00278	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—DECR1—malaria	0.000113	0.00264	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—DHFR—malaria	0.00011	0.00258	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—SCARB1—malaria	0.000109	0.00255	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—malaria	0.000109	0.00254	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—TNF—malaria	0.000109	0.00254	CbGpPWpGaD
Rasagiline—BCL2—Immune System—IL18—malaria	9.27e-05	0.00217	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CD40LG—malaria	9.23e-05	0.00216	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CD8A—malaria	9.13e-05	0.00213	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—CD4—malaria	9e-05	0.0021	CbGpPWpGaD
Rasagiline—BCL2—Immune System—HLA-B—malaria	8.78e-05	0.00205	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CD36—malaria	8.61e-05	0.00201	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CRP—malaria	7.76e-05	0.00181	CbGpPWpGaD
Rasagiline—BCL2—Immune System—TLR4—malaria	7.44e-05	0.00174	CbGpPWpGaD
Rasagiline—BCL2—Immune System—ICAM1—malaria	7.14e-05	0.00167	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—CD36—malaria	6.85e-05	0.0016	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—DHODH—malaria	6.29e-05	0.00147	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—malaria	6.18e-05	0.00144	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—malaria	5.68e-05	0.00133	CbGpPWpGaD
Rasagiline—BCL2—Immune System—IFNG—malaria	5.43e-05	0.00127	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—SLC4A1—malaria	5.34e-05	0.00125	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CD4—malaria	5.24e-05	0.00123	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—DECR1—malaria	5.02e-05	0.00117	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—IL6—malaria	4.87e-05	0.00114	CbGpPWpGaD
Rasagiline—BCL2—Immune System—IL1B—malaria	4.84e-05	0.00113	CbGpPWpGaD
Rasagiline—BCL2—Immune System—IL2—malaria	4.83e-05	0.00113	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—HBB—malaria	4.54e-05	0.00106	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PKLR—malaria	4.05e-05	0.000946	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—G6PD—malaria	3.61e-05	0.000844	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—CD36—malaria	3.56e-05	0.000832	CbGpPWpGaD
Rasagiline—BCL2—Immune System—IL6—malaria	2.84e-05	0.000663	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—HPGDS—malaria	2.75e-05	0.000643	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—DHFR—malaria	2.55e-05	0.000597	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—SCARB1—malaria	2.53e-05	0.000591	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CD36—malaria	1.59e-05	0.000371	CbGpPWpGaD
